Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Agarwal, Hitesh K. | - |
dc.contributor.author | Khalil, Ahmed | - |
dc.contributor.author | Ishita, Keisuke | - |
dc.contributor.author | Yang, Weilian | - |
dc.contributor.author | Nakkula, Robin J. | - |
dc.contributor.author | Wu, Lai-Chu | - |
dc.contributor.author | Ali, Tehane | - |
dc.contributor.author | Tiwari, Rohit | - |
dc.contributor.author | Byun, Youngjoo | - |
dc.contributor.author | Barth, Rolf F. | - |
dc.contributor.author | Tjarks, Werner | - |
dc.date.accessioned | 2021-09-04T14:15:58Z | - |
dc.date.available | 2021-09-04T14:15:58Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2015-07-15 | - |
dc.identifier.issn | 0223-5234 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/93010 | - |
dc.description.abstract | A library of sixteen 2nd generation amino- and amido-substituted carboranyl pyrimidine nucleoside analogs, designed as substrates and inhibitors of thymidine kinase 1 (TK1) for potential use in boron neutron capture therapy (BNCT) of cancer, was synthesized and evaluated in enzyme kinetic-, enzyme inhibition-, metabolomic-, and biodistribution studies. One of these 2nd generation carboranyl pyrimidine nucleoside analogs (YB18A [3]), having an amino group directly attached to a meta-carborane cage tethered via ethylene spacer to the 3-position of thymidine, was approximately 3-4 times superior as a substrate and inhibitor of hTK1 than N5-20H (2), a 1st generation carboranyl pyrimidine nucleoside analog. Both 2 and 3 appeared to be 5'-monophosphorylated in TK1(+) RG2 cells, both in vitro and in vivo. Biodistribution studies in rats bearing intracerebral RG2 glioma resulted in selective tumor uptake of 3 with an intratumoral concentration that was approximately 4 times higher than that of 2. The obtained results significantly advance the understanding of the binding interactions between TK1 and carboranyl pyrimidine nucleoside analogs and will profoundly impact future design strategies for these agents. (C) 2015 Elsevier Masson SAS. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER | - |
dc.subject | DEOXYRIBONUCLEOSIDE KINASES | - |
dc.subject | BIOLOGICAL EVALUATION | - |
dc.subject | QUATERNARY STRUCTURE | - |
dc.subject | DELIVERY AGENTS | - |
dc.subject | CELLS | - |
dc.subject | CYTOTOXICITY | - |
dc.subject | ALKYL | - |
dc.title | Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Byun, Youngjoo | - |
dc.identifier.doi | 10.1016/j.ejmech.2015.05.042 | - |
dc.identifier.scopusid | 2-s2.0-84931262600 | - |
dc.identifier.wosid | 000358097200020 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.100, pp.197 - 209 | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.title | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.volume | 100 | - |
dc.citation.startPage | 197 | - |
dc.citation.endPage | 209 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.subject.keywordPlus | DEOXYRIBONUCLEOSIDE KINASES | - |
dc.subject.keywordPlus | BIOLOGICAL EVALUATION | - |
dc.subject.keywordPlus | QUATERNARY STRUCTURE | - |
dc.subject.keywordPlus | DELIVERY AGENTS | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | CYTOTOXICITY | - |
dc.subject.keywordPlus | ALKYL | - |
dc.subject.keywordAuthor | Carboranyl pyrimidine nucleoside analog | - |
dc.subject.keywordAuthor | Thymidine kinase 1 (TK1) | - |
dc.subject.keywordAuthor | Carborane | - |
dc.subject.keywordAuthor | Boron neutron capture therapy (BNCT) | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.